Latest / Early Edition with Ryan Bridge / Robin van der Sanden: 2024 New Zealand Drugs Trends Survey author on the findings of the report

Transcript

Robin van der Sanden: 2024 New Zealand Drugs Trends Survey author on the findings of the report · Early Edition with Ryan Bridge

• 0:00
  Speaker 1: So we've got a second lot of findings from a
• 0:01
  Speaker 1: massive university drug trends survey and they're a bit of
• 0:04
  Speaker 1: a worry. One in four survey responders report using pharmaceuticals
• 0:08
  Speaker 1: for recreational use over the past six months. Twenty four
• 0:11
  Speaker 1: percent report using MDMA and ketamine and other psychedelics for
• 0:15
  Speaker 1: therapeutic purposes. And from the team the massive University in
• 0:19
  Speaker 1: New Zealand Drugs research team, I'm joined by doctor Robin
• 0:23
  Speaker 1: van Dersand and hello Robin, Hi, how are you very good?
• 0:27
  Speaker 1: So to the pharmaceuticals, First, do we have an illegal
• 0:30
  Speaker 1: trade in pharmaceuticals and people are sort of selling tramadol
• 0:33
  Speaker 1: to each other?
• 0:35
  Speaker 2: Potentially a little bit but also potentially a bit more
• 0:38
  Speaker 2: boring than that that people are just you know, sharing
• 0:40
  Speaker 2: these drugs with one another when in need. But there
• 0:44
  Speaker 2: is definitely also a little bit of sale going on.
• 0:46
  Speaker 1: So what should we be worried about with the pharmaceuticals.
• 0:50
  Speaker 2: A big thing is sort of health and safety. I
• 0:52
  Speaker 2: think you know a lot of people who take these
• 0:55
  Speaker 2: drugs nor medically might not have gotten the advice of
• 0:58
  Speaker 2: their doctor. You know, they might also be mixing these
• 1:01
  Speaker 2: drugs together. For example, with alcohol, which is a big
• 1:05
  Speaker 2: risk in terms of overdose or poisoning or experiencing harmful effects.
• 1:09
  Speaker 2: And also we've got as people are buying these drugs
• 1:12
  Speaker 2: illegally via a drug dealer, then we've got this risk
• 1:16
  Speaker 2: of them buying counterfeit pharmaceuticals.
• 1:19
  Speaker 1: Yes, indeed, and meanwhile to the more traditional drugs, the
• 1:23
  Speaker 1: mtumaze et cetera. You're saying, and you've said in your report,
• 1:26
  Speaker 1: the world is in the midst of a psychedelic renaissance.
• 1:28
  Speaker 1: Now what do you mean by that?
• 1:30
  Speaker 2: Well, it sort of means that we've got a kind
• 1:33
  Speaker 2: of really renewed interest in psychedelics across different areas of
• 1:39
  Speaker 2: society and in the medical sector in terms of healthcare.
• 1:44
  Speaker 2: You know, there's a lot of research on the potential
• 1:47
  Speaker 2: benefits of psychedelics for a number of mental health benefits
• 1:51
  Speaker 2: and therapeutic purposes. You've got a lot of cultural coverage
• 1:54
  Speaker 2: of psychedelics, so it's quite a sort of zeitgeist more
• 1:58
  Speaker 2: broadly in the culture at them. So that's kind of
• 2:00
  Speaker 2: what I mean.
• 2:01
  Speaker 1: By that, and one that we need to take great
• 2:03
  Speaker 1: care of. And I thank you Robin vanderstanding
• 2:06
  Speaker 2: For more from early edition with Ryan Bridge listen live
• 2:09
  Speaker 2: to news talks it be from five am weekdays, or
• 2:12
  Speaker 2: follow the podcast on iHeartRadio